Home
About us
Projects
- SpagoPix
- Tumorad
Nanomedicine
- The EPR-effect
- Companion Diagnostics
Publications
Investors
Media
Contact

Home
About us
Projects
- SpagoPix
- Tumorad
Nanomedicine
- The EPR-effect
- Companion Diagnostics
Publications
Investors
Media
Contact

Redeye

Analyst: Klas Palin
klas.palin@redeye.se

Latest research on Spago Nanomedical

Spago Nanomedical develops nanomaterials for improved cancer diagnostics and treatment

News

Spago Nanomedical participates in EU NANO2ALL project
Apr 25 2018
SpagoPix featured in international media
Oct 5 2017
FDA votes for further warnings for gadolinium-based contrast agents
Sep 11 2017

Press releases

Spago Nanomedical to be granted US patent for Tumorad®
Mar 5 2018
Spago Nanomedical directs share issue of 8.7 MSEK to HealthInvest Small & MicroCap Fund
Mar 1 2018
SpagoNanomedical select ChemConnection for SpagoPix production to supply clinical trials
Dec 5 2017

Copyright

© 2016 Spago Nanomedical AB.
All rights reserved

Address

Scheelevägen 22
SE-223 63 Lund, Sweden

LinkedIn

Home
About us
Projects
Nanomedicine
Publications
Investors
Media
Contact